Exchange traded funds that follow healthcare stocks and providers of medical devices were in negative territory Tuesday following weak quarterly results and a disappointing outlook from Medtronic (NYSE: MDT).
“Not a great quarter,” Deutsche Bank analysts said in their quick take on Medtronic’s results. Earlier this month, the company named Omar Ishrak as its chief executive.
Medtronic is about 11% of iShares Dow Jones US Medical Devices (NYSEArca: IHI), which was fractionally lower Tuesday, as was Health Care Select Sector SPDR Fund (NYSEArca: XLV).
iShares Dow Jones US Medical Devices
The opinions and forecasts expressed herein are solely those of John Spence, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.